Organigram Global Inc. operates as a publicly traded corporate entity rather than being owned by a single private individual. Its ownership is shared collectively among millions of public market investors, mutual funds, institutional entities, and its single largest strategic corporate partner, British American Tobacco, which maintains a roughly 30% controlling equity interest backed by multi-tranche investment agreements.